These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24008296)

  • 21. Does antiviral therapy prevent hepatocellular carcinoma?
    Kwon H; Lok AS
    Antivir Ther; 2011; 16(6):787-95. PubMed ID: 21900710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of hepatitis C virus eradication on hepatocellular carcinogenesis.
    Li DK; Chung RT
    Cancer; 2015 Sep; 121(17):2874-82. PubMed ID: 26079399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chronic hepatitis C].
    Grammatikos G; Sarrazin C
    Dtsch Med Wochenschr; 2010 Dec; 135(50):2525-34; quiz 2535-8. PubMed ID: 21140330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term evaluation of interferon therapy in hepatitis C virus-associated cirrhosis: does IFN prevent development of hepatocellular carcinoma?
    Tanaka K; Sata M; Uchimura Y; Suzuki H; Tanikawa K
    Oncol Rep; 1998; 5(1):205-8. PubMed ID: 9458323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The eradication of HCV.
    De Nicola S; Colombo M
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):63-75. PubMed ID: 26446686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon reduces the risk of hepatocellular carcinoma in hepatitis C virus-related chronic hepatitis/liver cirrhosis.
    Masuzaki R; Yoshida H; Omata M
    Oncology; 2010 Jul; 78 Suppl 1():17-23. PubMed ID: 20616579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus-induced hepatocellular carcinoma.
    Goossens N; Hoshida Y
    Clin Mol Hepatol; 2015 Jun; 21(2):105-14. PubMed ID: 26157746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular carcinoma and hepatitis C in the United States.
    El-Serag HB
    Hepatology; 2002 Nov; 36(5 Suppl 1):S74-83. PubMed ID: 12407579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.
    Hoshida Y; Fuchs BC; Bardeesy N; Baumert TF; Chung RT
    J Hepatol; 2014 Nov; 61(1 Suppl):S79-90. PubMed ID: 25443348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention and treatment of hepatocellular carcinoma.
    Omata M; Yoshida H
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S111-4. PubMed ID: 14762850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.
    Lodato F; Mazzella G; Festi D; Azzaroli F; Colecchia A; Roda E
    World J Gastroenterol; 2006 Dec; 12(45):7239-49. PubMed ID: 17143937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of hepatitis C virus-related hepatocellular carcinoma.
    Heathcote EJ
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S294-302. PubMed ID: 15508097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia.
    Sievert W; Razavi H; Estes C; Thompson AJ; Zekry A; Roberts SK; Dore GJ
    J Gastroenterol Hepatol; 2014 Aug; 29 Suppl 1():1-9. PubMed ID: 25055928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma.
    Caselmann WH; Alt M
    J Hepatol; 1996; 24(2 Suppl):61-6. PubMed ID: 8836891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma.
    Desjardins LA
    Clin J Oncol Nurs; 2002; 6(2):107-8. PubMed ID: 11889672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and anticarcinogenic activity of ribavirin combination therapy for hepatitis C virus-related compensated cirrhosis.
    Akuta N; Suzuki F; Seko Y; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    Intervirology; 2013; 56(1):37-45. PubMed ID: 23037768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
    Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus infection and hepatocellular carcinoma.
    Blonski W; Reddy KR
    Clin Liver Dis; 2008 Aug; 12(3):661-74, x. PubMed ID: 18625433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatitis C].
    Moradpour D; Blum HE
    Ther Umsch; 2004 Aug; 61(8):493-8. PubMed ID: 15457965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.